Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 13 May 2026, has recommended a Final Dividend of Rs.57 per share (i.e.570%), subject to the approval of the shareholders.